Lendin (Bilastine)

Bilastine works by selectively blocking peripheral H1 histamine receptors, preventing histamine from binding and triggering the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation, thereby reducing typical allergic signs such as itching, swelling, and nasal discharge.

The appropriate dose of Lendin is determined by a qualified prescriber based on the patient’s age, condition, and clinical response. Patients should follow the dosing instructions provided on the prescription label and not adjust the dose without medical advice.

Safety data for bilastine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare professional before using Lendin.

To place an order, submit an enquiry on the Lendin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Bilastine, the active ingredient in Lendin, offers a high degree of selectivity for peripheral H1 receptors and minimal central nervous system penetration, which can result in lower sedation compared with first‑generation antihistamines. Its efficacy in allergic rhinitis and urticaria is comparable to other second‑generation agents such as cetirizine or loratadine.

Lendin should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keeping the tablets in a dry place helps maintain their stability and potency throughout the shelf life.

Lendin is taken orally, usually as a single tablet per day, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water; do not crush or chew it unless specifically instructed.

While generally well tolerated, serious adverse reactions can include anaphylaxis, Stevens‑Johnson syndrome, angioedema, and rare cardiac arrhythmias. Patients should seek immediate medical attention if they experience signs of severe allergic reaction such as difficulty breathing, swelling of the face or throat, or widespread rash.

Lendin is contraindicated in individuals with known hypersensitivity to bilastine or any of the tablet’s excipients. Patients with severe renal impairment should use it only under medical supervision, and those taking interacting medications listed under major interactions should avoid concurrent use.